Prospective Tumor Response Evaluation

Stopped early

Conditions studied: Hepatocellular Cancer, Metastatic Liver Cancer

In brief

The purpose of this study is to determine if MRI imaging can detect genetic, proteomic, and metabolomic characteristics of liver tumors. The study also aims to determine if these imaging characteristics are correlated with clinical outcomes.

Key facts

Study ID

NCT02787954

Run by

The University of Texas Health Science Center, Houston

People needed

10

Starts

2016-01-01

Expected to finish

2017-04-01

Last updated by the study team

2018-10-18

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis or suspicion of primary or metastatic liver cancer deemed eligible for TACE, Y-90, percutaneous ablation, and /or electroporation.

You may not qualify if…

• Any reason MRI cannot be obtained.

Where it is running

• University of Texas Health Science Center Houston — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.